Genetic background of primary iron overload syndromes in Japan

Hisao Hayashi1, Shinya Wakusawa, Satoshi Motonishi

  • 1Department of Medicine, Aichi Gakuin University School of Pharmacy, Nagoya.

Insights

Genetic factors influence iron overload syndromes in Japanese individuals. Researchers identified mutations in TFR2, HJV, FTH1, and SLC40A1 genes, clarifying genetic causes and phenotype-genotype correlations in primary iron overload.

Area of Science:

  • Genetics
  • Internal Medicine
  • Molecular Biology

Background:

  • Iron overload syndromes exhibit varying prevalence between ethnic groups, potentially due to genetic differences.
  • The genetic basis of primary iron overload in Japanese populations remains incompletely understood.

Purpose of the Study:

  • To investigate the genetic underpinnings of primary iron overload syndromes in Japanese patients.
  • To identify specific gene mutations associated with different iron overload phenotypes in Japan.

Main Methods:

  • Genetic analysis of patients with primary iron overload syndromes.
  • Screening for mutations in key genes including HFE, TFR2, HJV, FTH1, and SLC40A1.
  • Phenotype-genotype correlation analysis.

Main Results:

  • The HFE C282Y mutation, common in Caucasians, was found in a Japanese patient.
  • Mutations in the transferrin receptor gene (TFR2) were identified as a major cause of hemochromatosis in Japanese families.
  • Mutations in hemojuvelin (HJV), H ferritin (FTH1), and SLC40A1 (ferroportin disease) were also found, alongside cases with no identified mutations.

Conclusions:

  • The genetic landscape of primary iron overload in Japan involves multiple genes, including TFR2 as a significant contributor.
  • Identified mutations provide partial clarification of genetic backgrounds and reveal phenotype-genotype correlations in Japanese patients.
  • Further research is needed to elucidate the genetic basis of iron overload in cases lacking mutations in the investigated genes.

Related Concept Videos

Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...